Stay updated on Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision history updated: added v3.4.3 and removed v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T18:06:16.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Site-wide maintenance updates include a new Revision: v3.4.2 and the removal of a prior government funding/operating status notice. These changes do not modify the study details, eligibility criteria, outcomes, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:57:06.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T04:43:06.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Additions include showing the glossary and new footer metadata: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Deletions remove the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T02:27:26.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page. No substantive changes to study details or navigation are indicated.
    Difference
    0.0%
    Check dated 2026-01-14T01:35:26.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations are reorganized with a new top-level 'Locations' heading and updated state listings (New South Wales, Queensland, South Australia, Victoria, Western Australia). The HHS Vulnerability Disclosure footer link was removed and revision numbers updated from v3.3.2 to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-23T10:10:10.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial page.